Ambulatory Surgery Centers (ASCs) are becoming increasingly important sites for conducting clinical trials, particularly in specialized therapeutic areas like gastrointestinal (GI) and hepatology research. Efficient operations, patient recruitment, and regulatory compliance at these centers are critical factors that can determine the success or delay of a clinical trial.
A recent article on Becker’s ASC Review highlights the evolving landscape of ASCs in clinical research, emphasizing the need for streamlined processes and integrated technology solutions to overcome common challenges. At Iterative Health, we share this vision and have developed tailored solutions to support ASCs and clinical research sites globally.
Challenges Facing Ambulatory Surgery Centers in Clinical Trials
ASCs face unique hurdles in clinical trial execution, including limited bandwidth for research staff, complex regulatory requirements, and difficulty in patient recruitment—especially in rare disease studies. These challenges can lead to delays in site activation, slower enrollment rates, and increased operational costs.
Traditional site management approaches often fall short in addressing these issues because they lack integration with advanced technology and real-time data insights. Without proactive support, ASCs risk missing critical milestones, which can extend trial timelines and increase costs.
How Iterative Health Supports ASCs to Accelerate Clinical Trials
Iterative Health partners with ASCs and other clinical research sites to provide end-to-end operational support that combines deep clinical expertise with AI-powered tools. Our solutions are designed to reduce the burden on site staff, improve patient identification and retention, and streamline regulatory compliance.
Key benefits of partnering with Iterative Health include:
- Faster site activation: Our proven operational workflows accelerate trial start-up, reducing time-to-first patient enrolled.
- Improved patient recruitment and retention: Leveraging AI-driven patient matching and proactive chart reviews, we identify eligible candidates and support ongoing engagement to reduce dropout rates.
- Regulatory and sponsor communication: We facilitate clear, timely communication between sites, sponsors, and CROs, ensuring alignment and efficient issue resolution.
- Scalable tech-enabled services: From custom dashboards to automated reporting, our platform equips ASCs to manage trial complexities with greater accuracy and less manual effort.
Real-World Impact: Accelerated Enrollment and Operational Efficiency
One of our recent collaborations with Gastro One on a challenging Phase 1b-A trial for a rare GI disease demonstrated the power of targeted operational support. In just five months, Gastro One achieved record patient enrollment, including two patient randomizations—an exceptional milestone given the rarity of the condition and the trial’s complexity.
This success underscores the importance of combining expert site support with advanced technology to meet demanding trial requirements without overburdening clinical teams.
Why Choose Iterative Health for Your ASC Clinical Trials?
Our extensive network of over 80 clinical research sites across the US and Europe positions Iterative Health as a premier partner for sponsors and research organizations seeking to accelerate clinical trials. We understand the operational nuances of ASCs and tailor our services to their specific needs, ensuring faster time-to-market for novel therapies.
We are committed to driving clinical trial innovation by empowering research teams with tools and support that enhance productivity and improve patient outcomes.
For a detailed discussion on ASC clinical trials, read the original article on Becker’s ASC Review here.
About Iterative Health
Iterative Health is a healthcare technology and services company powering the acceleration of clinical research to transform patient outcomes. By combining deep expertise in clinical trials with cutting-edge AI, we empower research teams and study sponsors to expand and expedite access to novel therapeutics for patients in need. Today, Iterative Health is based in Cambridge, Massachusetts, and New York City with 250+ employees world-wide.
To learn more or explore a partnership, please visit our Contact page.